Item 5.07. Submission of Matters to a Vote of Security Holders.
At the 2021 Annual Meeting of Shareholders of Regeneron Pharmaceuticals, Inc.
("Regeneron" or the "Company") held on June 11, 2021, Regeneron's shareholders
voted on the matters set forth below.
Proposal 1 - Election of Directors
The following nominees for Class III directors were elected to serve until the
2024 Annual Meeting of Shareholders and until their successors are duly elected
and qualified based upon the following votes:
Nominee For Against Abstain Broker Non-Votes
N. Anthony Coles, M.D. 75,381,886 32,535,136
Arthur F. Ryan 86,030,481 21,860,350 104,328 5,619,610
George L. Sing 54,880,615 53,055,342 59,202 5,619,610
Marc Tessier-Lavigne, Ph.D. 72,073,887 35,848,999
Proposal 2 - Ratification of Appointment of Independent Registered Public
The proposal to ratify the appointment of PricewaterhouseCoopers LLP as the
Company's independent registered public accounting firm for the fiscal year
ending December 31, 2021 was approved based upon the following votes:
© Edgar Online, source Glimpses